TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33127554

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP) injection
Number of subjects: 99

Group type: COMPARATOR
Intervention: Corticosteroid (CS) injection
Number of subjects: 99
Study: 34459702

Group type: EXPERIMENTAL
Intervention: 90Y-ibritumomab-tiuxetan 0.4 mCi/kg (arm A)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Rituximab 375 mg/m2 every 8 weeks for 2 years (arm B)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: 90Y-ibritumomab-tiuxetan (arm A)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Rituximab (arm B)
Number of subjects: 146
Study: 33765549

Group type: EXPERIMENTAL
Intervention: Integrated yoga for 4 weeks
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 79
Study: 34243616

Group type: EXPERIMENTAL
Intervention: Intravenous fixed-dose combination (FDC) of acetaminophen 1000 mg + ibuprofen 300 mg administered 6-hourly as a 5 min infusion for 48 hours to 5 days
Number of subjects: 232
Study: 32703005

Group type: EXPERIMENTAL
Intervention: HEMOBLAST Bellows (HB)
Number of subjects: 27
Study: 33431219

Group type: EXPERIMENTAL
Intervention: Axillary artery cannulation
Number of subjects: 111

Group type: COMPARATOR
Intervention: Innominate artery cannulation
Number of subjects: 111
Study: 33706319

Group type: EXPERIMENTAL
Intervention: Bridging therapy (BT)
Number of subjects: 623

Group type: COMPARATOR
Intervention: Primary mechanical thrombectomy (PMT)
Number of subjects: 623
Study: 32797236

Group type: EXPERIMENTAL
Intervention: Intranasal desmopressin (40 μg)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Intravenous paracetamol (15 mg/kg)
Number of subjects: 240
Study: 34265224

Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 66

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 66

Group type: COMPARATOR
Intervention: Reference (control)
Number of subjects: 66
Study: 32043426

Group type: EXPERIMENTAL
Intervention: arthroscopic microfracture plus intra‐articular injection of HA and haMPCs
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: arthroscopic microfracture and intra‐articular injection of HA
Number of subjects: 30

Group type: COMPARATOR
Intervention: arthroscopic microfracture group and normal saline injection
Number of subjects: 30
Study: 35941694

Group type: EXPERIMENTAL
Intervention: 12 anatomically varying cases in a VR simulator
Number of subjects: 24

Group type: COMPARATOR
Intervention: 12 identical cases in a VR simulator (Control group)
Number of subjects: 24
Study: 34474267

Group type: EXPERIMENTAL
Intervention: 10 mg intravenous (IV) metoclopramide
Number of subjects: 108

Group type: COMPARATOR
Intervention: 30 mg intravenous (IV) ketorolac
Number of subjects: 108
Study: 616121600

Group type: EXPERIMENTAL
Intervention: Idebenone (Raxone) 150 mg tablets
Number of subjects: 50
Study: 34557985

Group type: EXPERIMENTAL
Intervention: OTee HORSPLAY (occupational therapy in an equine environment) for 10 weeks
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: OTee HORSPLAY (occupational therapy in an equine environment)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Waitlist control condition (occupational therapy in a garden)
Number of subjects: 24
Study: 34006542

Group type: EXPERIMENTAL
Intervention: Morphine (2 mg subcutaneous injection)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36396069

Group type: EXPERIMENTAL
Intervention: Enhanced Smoking Cessation Approach to Promote Empowerment (ESCAPE) intervention
Number of subjects: 250

Group type: COMPARATOR
Intervention: Standard care (brief advice, referral to a quit line, and a lung cancer screening decision-aide)
Number of subjects: 250
Study: 33571464

Group type: EXPERIMENTAL
Intervention: Comprehensive training
Number of subjects: 168

Group type: COMPARATOR
Intervention: Limited training
Number of subjects: 168

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 168
Study: 33407963

Group type: EXPERIMENTAL
Intervention: Pre-operative computed tomography
Number of subjects: 42

Group type: COMPARATOR
Intervention: Matched pair analysis without pre-operative computed tomography
Number of subjects: 42
Study: 36125055

Group type: COMPARATOR
Intervention: Continuous paliperidone palmitate (PP) for 18 months (PP-PP)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Initial oral antipsychotic (OAP) switched to PP after 9 months (OAP-PP)
Number of subjects: 181
Study: 32076854

Group type: EXPERIMENTAL
Intervention: Neurofeedback (NF)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 35698094

Group type: EXPERIMENTAL
Intervention: Weekly screening + symptomatic testing
Number of subjects: 16

Group type: COMPARATOR
Intervention: Symptomatic testing only
Number of subjects: 16
Study: 32372281

Group type: EXPERIMENTAL
Intervention: Popliteus Bypass (Group PB; n=9)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Larson technique (Group FS; n=9)
Number of subjects: 18
Study: 33476593

Group type: EXPERIMENTAL
Intervention: Nivolumab (360 mg intravenously every 3 weeks) plus ipilimumab (1 mg/kg intravenously every 6 weeks) combined with histology-based, platinum doublet chemotherapy (intravenously every 3 weeks for two cycles)
Number of subjects: 719

Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab with two cycles of chemotherapy
Number of subjects: 719

Group type: COMPARATOR
Intervention: Chemotherapy alone (every 3 weeks for four cycles)
Number of subjects: 719

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 719
Study: 35419778

Group type: EXPERIMENTAL
Intervention: Exercise group (EG; exercise plus standard medical care)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (CG; standard medical care)
Number of subjects: 84
Study: 33756521

Group type: EXPERIMENTAL
Intervention: Auricular acupressure (AA) at HT7 points for 4 weeks
Number of subjects: 179

Group type: COMPARATOR
Intervention: Sleep hygiene instruction (SHI)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Auricular acupressure (AA)
Number of subjects: 179
Study: 35750724

Group type: EXPERIMENTAL
Intervention: Group A (rehearsal) - printouts with images of risks and handwritten descriptions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group B (audio-visual presentation) - PowerPoint presentation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 34623788

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Number of subjects: 1600

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 1600
Study: 32169403

Group type: EXPERIMENTAL
Intervention: Citalopram added to clinician-determined antipsychotic treatment
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 36137629

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (AE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neck-specific exercise (NSE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 0
Study: 33721696

Group type: EXPERIMENTAL
Intervention: Inhaled iloprost (5.0 μg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 32251031

Group type: EXPERIMENTAL
Intervention: Intrathecal Morphine
Number of subjects: 134

Group type: COMPARATOR
Intervention: Intrathecal Hydromorphone
Number of subjects: 134
Study: 35441772

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTX‐A)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (other hand)
Number of subjects: 16
Study: 34657589

Group type: EXPERIMENTAL
Intervention: RCT (Mpepu Study)
Number of subjects: 4010

Group type: COMPARATOR
Intervention: Cohort Study (Maikaelelo Study)
Number of subjects: 4010
Study: 33819363

Group type: EXPERIMENTAL
Intervention: Intervention clubs (24 clubs) received feedback letters regarding staff sales behaviour and awareness building activities.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Comparison clubs (22 clubs) did not receive the intervention.
Number of subjects: 50
Study: 32434243

Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis with 160 mg trimethoprim combined with 800 mg sulfamethoxazole three times a week for 12 months (placebo-controlled double-blind study)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No prophylaxis (control group)
Number of subjects: 20
Study: 36130858

Group type: EXPERIMENTAL
Intervention: 15 minutes of choir singing
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard voice use (one-on-one conversation, no singing)
Number of subjects: 30
Study: 32559413

Group type: EXPERIMENTAL
Intervention: Lactoferrin supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 33966329

Group type: EXPERIMENTAL
Intervention: Prediction equations for estimating body weight in females aged 65-79 years using height, MUAC, WC, CC, and TST.
Number of subjects: 1456

Group type: EXPERIMENTAL
Intervention: Prediction equations for estimating body weight in females aged ≥ 80 years using height, MUAC, WC, CC, and TST.
Number of subjects: 1456

Group type: EXPERIMENTAL
Intervention: Prediction equations for estimating body weight in males aged 65-79 years using height, MUAC, WC, CC, and TST.
Number of subjects: 1456

Group type: EXPERIMENTAL
Intervention: Prediction equations for estimating body weight in males aged ≥ 80 years using height, MUAC, WC, CC, and TST.
Number of subjects: 1456
Study: 32367737

Group type: EXPERIMENTAL
Intervention: High-recruiters
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Medium-recruiters
Number of subjects: 96

Group type: COMPARATOR
Intervention: Non-recruiters and low-recruiters
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Overall recruitment results
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Recruitment timing
Number of subjects: 96
Study: 34959148

Group type: EXPERIMENTAL
Intervention: 200 µg misoprostol
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: 400 µg misoprostol
Number of subjects: 211
Study: 33320019

Group type: EXPERIMENTAL
Intervention: Zopiclone 5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zopiclone 10 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ethanol (50 grams)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35428739

Group type: EXPERIMENTAL
Intervention: Microsurgical intervention (MSIG)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group 1 (CG1)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group 2 (CG2)
Number of subjects: 47
Study: 33960676

Group type: EXPERIMENTAL
Intervention: Acrylic terpolymer (T1) skin protectant
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Zinc oxide (T2) skin protectant
Number of subjects: 84

Group type: COMPARATOR
Intervention: Disposable body wipes and zinc oxide protectant (Control)
Number of subjects: 84
Study: 32476617

Group type: EXPERIMENTAL
Intervention: Active VNS
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control VNS
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Active VNS (after crossover from Control VNS)
Number of subjects: 17
Study: 93045359

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 21

Group type: COMPARATOR
Intervention: Open cholecystectomy
Number of subjects: 21
Study: 35784544

Group type: EXPERIMENTAL
Intervention: NIFI group (using autofluorescence and indocyanine green fluorescence imaging)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (naked eye identification)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: NIFI group
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: NIFI group (with at least one well‐perfused PG)
Number of subjects: 180
Study: 32046747

Group type: EXPERIMENTAL
Intervention: Pycnogenol supplementation of 150 mg for 10 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33130256

Group type: EXPERIMENTAL
Intervention: Best-corrected visual acuity (BCVA) and central subfield thickness (CST) correlation for ME from RVO
Number of subjects: 1063

Group type: EXPERIMENTAL
Intervention: Best-corrected visual acuity (BCVA) and central subfield thickness (CST) correlation for DME
Number of subjects: 1063

Group type: EXPERIMENTAL
Intervention: Best-corrected visual acuity (BCVA) and central subfield thickness (CST) correlation for ME from NIU
Number of subjects: 1063

Group type: EXPERIMENTAL
Intervention: Change from baseline to 24 weeks for BCVA and CST for ME from RVO
Number of subjects: 1063

Group type: EXPERIMENTAL
Intervention: Change from baseline to 24 weeks for BCVA and CST for DME
Number of subjects: 1063

Group type: EXPERIMENTAL
Intervention: Change from baseline to 24 weeks for BCVA and CST for ME from NIU
Number of subjects: 1063

Group type: EXPERIMENTAL
Intervention: Central subfield EZ grades and mean BCVA
Number of subjects: 1063

Group type: EXPERIMENTAL
Intervention: Change in BCVA at 24 weeks for eyes with normal baseline central subfield EZ
Number of subjects: 1063
Study: 35801750

Group type: EXPERIMENTAL
Intervention: Anteroposterior real-time fluoroscopy
Number of subjects: 200

Group type: COMPARATOR
Intervention: Lateral real-time fluoroscopy
Number of subjects: 200
Study: 34197227

Group type: EXPERIMENTAL
Intervention: 100% O2 (peripheral chemoreceptor inhibition)
Number of subjects: 19

Group type: COMPARATOR
Intervention: 21% O2 (control session)
Number of subjects: 19
Study: 33310452

Group type: EXPERIMENTAL
Intervention: Bipolar disorder patients
Number of subjects: 13079

Group type: COMPARATOR
Intervention: Schizophrenia patients
Number of subjects: 13079

Group type: COMPARATOR
Intervention: General population
Number of subjects: 13079
Study: 33021477

Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg subcutaneous injection
Number of subjects: 17
Study: 35796769

Group type: EXPERIMENTAL
Intervention: Treatment as usual informed by autofluorescence imaging
Number of subjects: 56

Group type: COMPARATOR
Intervention: Treatment as usual alone (control)
Number of subjects: 56
Study: 34374108

Group type: EXPERIMENTAL
Intervention: Duloxetine 60mg daily for 6 weeks (5 weeks full dose and 1 week taper)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 33121372

Group type: EXPERIMENTAL
Intervention: FF/UMEC/VI 100/62.5/25 µg
Number of subjects: 499

Group type: COMPARATOR
Intervention: FF/VI 100/25 µg
Number of subjects: 499

Group type: COMPARATOR
Intervention: UMEC/VI 62.5/25 µg
Number of subjects: 499
Study: 34449495

Group type: EXPERIMENTAL
Intervention: Comparison-based approach
Number of subjects: 126

Group type: COMPARATOR
Intervention: Traditional approach
Number of subjects: 126
Study: 32165813

Group type: EXPERIMENTAL
Intervention: Graded Activity (GA)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Graded Activity with Daily-Monitored-Walking (GAMW)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Comparison between GA and GAMW
Number of subjects: 58
Study: 32880214

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Moderate continuous training
Number of subjects: 0
Study: 35187867

Group type: COMPARATOR
Intervention: Moderate-intensity exercise (moderate-Ex) for 24 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Low-intensity exercise (low-Ex) for 24 weeks
Number of subjects: 50
Study: 34444779

Group type: EXPERIMENTAL
Intervention: Cranberry juice (500 mL/d; 27% cranberry juice)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo juice
Number of subjects: 40
Study: 32087269

Group type: EXPERIMENTAL
Intervention: Indian Diabetic Risk Score (IDRS)
Number of subjects: 240000
Study: 36445862

Group type: EXPERIMENTAL
Intervention: Partial randomized response technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Existing randomized response techniques
Number of subjects: 0
Study: 33527566

Group type: EXPERIMENTAL
Intervention: G_2D
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: G_4D
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: G_7D
Number of subjects: 16

Group type: COMPARATOR
Intervention: G_Control
Number of subjects: 16
Study: 33046527

Group type: EXPERIMENTAL
Intervention: Patients without recurrent AT/AF
Number of subjects: 518

Group type: COMPARATOR
Intervention: Patients with recurrent AT/AF
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: Overall cohort
Number of subjects: 518
Study: 34424347

Group type: EXPERIMENTAL
Intervention: Laparoscopic mesh sacrohysteropexy (LSH)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Vaginal hysterectomy with apical suspension (VH)
Number of subjects: 101
Study: 34737281

Group type: EXPERIMENTAL
Intervention: Tremelimumab with cryoablation
Number of subjects: 29

Group type: COMPARATOR
Intervention: Tremelimumab without cryoablation
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both arms (Tremelimumab with and without cryoablation)
Number of subjects: 29
Study: 35289377

Group type: EXPERIMENTAL
Intervention: Sensory block testing from anesthetized area to nonanesthetized area
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sensory block testing from nonanesthetized area to anesthetized area
Number of subjects: 31
Study: 32075686

Group type: EXPERIMENTAL
Intervention: Screening Only group - ADRD screening at baseline and disclosure of results, with positive-screen participants receiving a list of local resources for diagnostic follow-up.
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: Screening Plus group - ADRD screening at baseline with disclosure of results, positive-screen participants referred to a dementia collaborative care program for diagnostic evaluation and potential care.
Number of subjects: 1800

Group type: COMPARATOR
Intervention: Control group - No screening.
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: Both Screening Only and Screening Plus groups.
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: Screening Only versus Screening Plus groups.
Number of subjects: 1800
Study: 33528914

Group type: EXPERIMENTAL
Intervention: Liraglutide 3.0 mg daily
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 32077553

Group type: EXPERIMENTAL
Intervention: 1 g of IV acetaminophen + 1 mg of IV hydromorphone
Number of subjects: 162

Group type: COMPARATOR
Intervention: Placebo + 1 mg of IV hydromorphone
Number of subjects: 162
Study: 36763995

Group type: EXPERIMENTAL
Intervention: Remimazolam-alfentanil
Number of subjects: 161

Group type: COMPARATOR
Intervention: Propofol-alfentanil
Number of subjects: 161
Study: 32205036

Group type: EXPERIMENTAL
Intervention: Automated spirit presence and communication technology (total hardware cost per system less than $4,000)
Number of subjects: 0
Study: 34318607

Group type: EXPERIMENTAL
Intervention: Sovesudil 0.5% TID
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Sovesudil 0.25% TID
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119

Group type: COMPARATOR
Intervention: Sovesudil 0.5% TID vs Placebo
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Sovesudil (both doses)
Number of subjects: 119
Study: 33780901

Group type: EXPERIMENTAL
Intervention: Bolgerization
Number of subjects: 41

Group type: COMPARATOR
Intervention: Partial resection
Number of subjects: 41
Study: 33159373

Group type: EXPERIMENTAL
Intervention: PTSD Coach Online-Arabic
Number of subjects: 87
Study: 36472309

Group type: EXPERIMENTAL
Intervention: Mandibular advancement device (MAD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: New 'boil and bite' MAD
Number of subjects: 0

Group type: COMPARATOR
Intervention: Custom MAD
Number of subjects: 0
Study: 34632925

Group type: EXPERIMENTAL
Intervention: Dolcanatide 27 mg daily for 7 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (implied control)
Number of subjects: 0
Study: 32056528

Group type: EXPERIMENTAL
Intervention: 70% sterile honey‐based ophthalmic formulation
Number of subjects: 50

Group type: COMPARATOR
Intervention: 0.3% ophthalmic ciprofloxacin
Number of subjects: 50
Study: 33080740

Group type: EXPERIMENTAL
Intervention: IV lidocaine at 1.5 mg/kg
Number of subjects: 138

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 138
Study: 35857170

Group type: EXPERIMENTAL
Intervention: Clinical pilates exercises for 6 weeks
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Clinical pilates exercises
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (posture education)
Number of subjects: 50
Study: 33340153

Group type: EXPERIMENTAL
Intervention: DE graft (DE+)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PI graft (PI+)
Number of subjects: 60
Study: 32585425

Group type: EXPERIMENTAL
Intervention: Skidmore Anxiety Stigma Scale (SASS)
Number of subjects: 270
Study: 34407441

Group type: EXPERIMENTAL
Intervention: Nigella sativa oil (NSO) 500 mg twice daily for 10 days
Number of subjects: 173

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Nigella sativa oil (NSO)
Number of subjects: 173
Study: 33272080

Group type: EXPERIMENTAL
Intervention: Attune total knee replacement
Number of subjects: 42
Study: 34800794

Group type: COMPARATOR
Intervention: dHACM Sheet
Number of subjects: 40

Group type: COMPARATOR
Intervention: dHACM Injection
Number of subjects: 40

Group type: COMPARATOR
Intervention: No Treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: dHACM-treated animals
Number of subjects: 40
Study: 33798297

Group type: EXPERIMENTAL
Intervention: Epidural labor analgesia
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: TEAS combined with epidural labor analgesia
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no labor analgesia)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Epidural group
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Combination group (TEAS + epidural)
Number of subjects: 120
Study: 32538733

Group type: EXPERIMENTAL
Intervention: Risk minimization measures
Number of subjects: 154
Study: 33825333

Group type: EXPERIMENTAL
Intervention: Foam and cream for rosacea patients (verum)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 33
Study: 33098300

Group type: EXPERIMENTAL
Intervention: Cognitive performance measured with the Brief Assessment of Cognition in Schizophrenia
Number of subjects: 767

Group type: EXPERIMENTAL
Intervention: Cognitive profiles
Number of subjects: 767

Group type: EXPERIMENTAL
Intervention: Latent transition analysis
Number of subjects: 767

Group type: EXPERIMENTAL
Intervention: Confirmatory factor analysis (CFA)
Number of subjects: 767

Group type: EXPERIMENTAL
Intervention: Cognitive subtyping
Number of subjects: 767
Study: 32078025

Group type: EXPERIMENTAL
Intervention: Treatment of body-focused repetitive behaviors
Number of subjects: 166